Company Insider Tape

TG Therapeutics Inc insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol TGTX Latest filing 11 Jun 2026

Company Read

Acquisition-led

TGTX has 5 stored insider filings. Acquisitions account for 100.0% of classified filings and disposals account for 0.0%.

Latest filing 11 Jun 2026most recent stored row
Largest filing $0reported transaction value
Total filings 5stored transaction rows
Acquisition value $05 acquisitions
Disposal value $00 disposals
Net value $0acquisitions minus disposals

Filing cadence

Last 12 active months
Jun 2026 5

Acquisitions 100.0% · Disposals 0.0%

Jun 2026 $0

Executive concentration

By filing count
CHARNEY, LAURENCE N Director · 1 filings
ECHELARD, YANN Director · 1 filings
HOBERMAN, KENNETH Director · 1 filings
HUME, DANIEL Director · 1 filings
LONIAL, SAGAR Director · 1 filings

Market Context

TGTX weekly market snapshot

Week 31 Jul 2026
Latest close 52.03 USDstored weekly close
1-week move -7.2%latest weekly bar
13-week move -2.4%medium-term context
Relative Strength 34.7Sharemaestro indicator
Fair value gap +89.9%price vs fair value
Trend signal 1smoothed trend state

Transaction History

Latest insider filings for TGTX

Showing 1-5 of 5
Date 11 Jun 2026
Insider CHARNEY, LAURENCE NDirector
Side Acquisition
Shares 8325
Price 0.00
Value 0
Security Stock Tracking Unit
Date 11 Jun 2026
Insider ECHELARD, YANNDirector
Side Acquisition
Shares 8325
Price 0.00
Value 0
Security Stock Tracking Unit
Date 11 Jun 2026
Insider HOBERMAN, KENNETHDirector
Side Acquisition
Shares 8325
Price 0.00
Value 0
Security Stock Tracking Unit
Date 11 Jun 2026
Insider HUME, DANIELDirector
Side Acquisition
Shares 8325
Price 0.00
Value 0
Security Stock Tracking Unit
Date 11 Jun 2026
Insider LONIAL, SAGARDirector
Side Acquisition
Shares 8325
Price 0.00
Value 0
Security Stock Tracking Unit